Inventor · disambiguated record
John Carter
Also filed as: CARTER JOHN · CARTER JOHN P · CARTER JOHN PAUL · CARTER JR JOHN P
22 granted patents·15 pending applications·121 citations·filing 1983–2024
94Inventor score
Files withAUSPEX PHARMACEUTICALS INC17ADRIA LAB INC3CURRAX PHARMACEUTICALS LLC3MARION LABORATORIES INC3PERNIX SLEEP INC3
Top patents by PatentIndex Score
37 records- 0196US10166183B2Pharmaceutical formulationsAUSPEX PHARMACEUTICALS INC·Filed 2015·Granted Jan 1, 2019·22 cites·21 claims
- 0294US9296739B2Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2014·Granted Mar 29, 2016·21 cites·27 claims
- 0394US9233959B2Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2014·Granted Jan 12, 2016·22 cites·27 claims
- 0492US12100521B2Nuclear reactor flow control devices and associated reactors, components, and methodsBATTELLE ENERGY ALLIANCE LLC·Filed 2022·Granted Sep 24, 2024·1 cites·19 claims
- 0590US9814708B2Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2016·Granted Nov 14, 2017·6 cites·39 claims
- 0690US9346800B2Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2013·Granted May 24, 2016·9 cites·20 claims
- 0789US2024366591A1Formulations and Pharmacokinetics of Deuterated Benzoquinoline Inhibitors of Vesicular Monoamine Transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0882US9550780B2Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2016·Granted Jan 24, 2017·4 cites·27 claims
- 0982US5001160A1-aryl-1-hydroxy-1-substituted-3-(4-substituted-1-piperazinyl)-2-propanones and their use in treatment of neurogenic bladder disordersMARION LABORATORIES INC·Filed 1989·Granted Mar 19, 1991·22 cites·12 claims
- 1082US2023355514A1Pharmaceutical formulationsAUSPEX PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1181US11033540B2Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2019·Granted Jun 15, 2021·0 cites·38 claims
- 1277US2021244723A1Formulations and Pharmacokinetics of Deuterated Benzoquinoline Inhibitors of Vesicular Monoamine Transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1376US10966922B2Pharmaceutical formulationsAUSPEX PHARMACEUTICALS INC·Filed 2019·Granted Apr 6, 2021·0 cites·16 claims
- 1475US9907780B2Low-dose doxepin formulations and methods of making and using the samePERNIX SLEEP INC·Filed 2016·Granted Mar 6, 2018·1 cites·20 claims
- 1574US2021205214A1Novel pharmaceutical formulationsAUSPEX PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1673US11666566B2Formulations and pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2020·Granted Jun 6, 2023·0 cites·18 claims
- 1773US2021322308A1Novel pharmaceutical formulationsAUSPEX PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1873US2022110908A1Low-Dose Doxepin Formulations And Methods Of Making And Using The SameCURRAX PHARMACEUTICALS LLC·Filed 2021·Application pending·0 cites
- 1972US2019133935A1Novel pharmaceutical formulationsAUSPEX PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 2070US9532971B2Low-dose doxepin formulations and methods of making and using the samePERNIX SLEEP INC·Filed 2013·Granted Jan 3, 2017·1 cites·10 claims
- 2169US11096920B2Low-dose doxepin formulations and methods of making and using the sameCURRAX PHARMACEUTICALS LLC·Filed 2020·Granted Aug 24, 2021·0 cites·20 claims
- 2269US2019083484A1Formulations And Pharmacokinetics Of Deuterated Benzoquinoline Inhibitors Of Vesicular Monoamine Transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 2365US10548871B2Low-dose doxepin formulations and methods of making and using the samePERNIX SLEEP INC·Filed 2018·Granted Feb 4, 2020·0 cites·20 claims
- 2463US2017087147A1Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2AUSPEX PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 2561US7939109B1Method of treating neoplastic disease in a human or animal patientCARTER JOHN·Filed 2000·Granted May 10, 2011·1 cites·15 claims
- 2661US2009074862A1Low-dose doxepin formulations and methods of making and using the sameSCHIOPPI LUIGI·Filed 2008·Application pending·0 cites
- 2761US2011318412A1Low dose doxepin formulations, including buccal, sublingual and fastmelt formulations, and uses of the same to treat insomniaSCHIOPPI LUIGI·Filed 2007·Application pending·0 cites
- 2859US4877779A2-aminomethylalkynylalkyl-1,3-dithiane derivativesMARION LABORATORIES INC·Filed 1988·Granted Oct 31, 1989·6 cites·4 claims
- 2956US7758899B2Pharmaceutical compositions and their use in the treatment of neoplastic diseaseCARTER JOHN·Filed 2004·Granted Jul 20, 2010·0 cites·14 claims
- 3054US4540814A1,4-Dimethoxy naphthalenecarboxamide anticonvulsantsADRIA LAB INC·Filed 1983·Granted Sep 10, 1985·4 cites·5 claims
- 3152US2009110727A1Extended release compositions of proton pump inhibitorsEISAI R&D MAN CO LTD·Filed 2005·Application pending·0 cites
- 3250US2007243249A1Novel formulation of pyridoxal-5'-phosphate and method of preparationFRIESEN ALBERT D·Filed 2005·Application pending·0 cites
- 3350US2020078295A1Low Dose Doxepin Formulations, Including Buccal, Sublingual And Fastmelt Formulations, And Uses Of The Same To Treat InsomniaCURRAX PHARMACEUTICALS LLC·Filed 2019·Application pending·0 cites
- 3442US4975437AIsomers of 1-azabicyclo(2.2.2)oct-3-yl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-5-nitropyridine-3-carboxylateMARION LABORATORIES INC·Filed 1989·Granted Dec 4, 1990·1 cites·8 claims
- 3540US2004170701A1Pharmaceutical composition comprising copper, salicylic acid, vitamin c and zinc for use in treatment of different diseases such as bacterial or viral infectionFiled 2002·Application pending·0 cites
- 3628US4831019APharmaceutical preparations of 4-demethoxy-n-trifluoroacetyl anthracyclinesADRIA LAB INC·Filed 1985·Granted May 16, 1989·0 cites·1 claims
- 3728US4590063AAnticonvulsantsADRIA LAB INC·Filed 1985·Granted May 20, 1986·0 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when John Carter files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →